Ignite Creation Date:
2025-12-25 @ 1:17 AM
Ignite Modification Date:
2025-12-27 @ 2:25 AM
Study NCT ID:
NCT00138593
Status:
COMPLETED
Last Update Posted:
2017-03-01
First Post:
2005-08-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Extension to a Study of the Efficacy and Safety of Vildagliptin in Patients With Type 2 Diabetes With Hemoglobin A1c (HbA1c) 9-11%
Sponsor:
Novartis
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-07
Start Date Type:
None
Primary Completion Date:
2006-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2006-07
Completion Date Type:
ACTUAL
First Submit Date:
2005-08-27
First Submit QC Date:
None
Study First Post Date:
2005-08-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-02-28
Last Update Post Date:
2017-03-01
Last Update Post Date Type:
ACTUAL